View Author
recombination rearrangement patient intronrs /iiia glycoprotein signal rss-intronrs trial inhibitor death joint treatment rss-kde table igk recombinations placebo segment event study 1·00 analysis infarction syndrome troponin control heparin treatment effect effect lancet publishing group revascularisation sequence element igk locus lancet ratio signal joints product deletion infusion 30 days configuration group primer result sample locus trial-specific odds ratios j rss-kde recombinations reduction intron-kde leukemia pseudohybrid baseline 30- j rss-intronrss difference allele m l simoons j rss-kde rearrangements chain van dongen primers excision women intronrss heptamer platelet b cells concentration level pcr products 5 days 1-emc b cell malignancies j gene segments j rss-intronrss signal table i randomisation tonsil investigator
2 Most Recent Publications
|
Unraveling the consecutive recombination events in the human IGK locus
(Article)
Langerak, A.W. Nadel, B. Torbal, A. de Wolvers-Tettero, I.L. Gastel-Mol, E.J. van Verhaaf, B. Jäger, U. Dongen, J.J.M. van |
2004-01-01
|
|
Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major ranodmised clinical trials
(Article)
Boersma, H. Harrington, R.A. Topol, E.J. Simoons, M.L. Armstrong, P.W. Werf, F.J.J. van de Moliterno, D.J. White, H.D. Théroux, P. Torbal, A. de Wallentin, L.C. Wilcox, R.G. Simes, R.J. Califf, R.M. |
2002-01-19
|
